Science

Jul 27, 2025, 13:03

Myeloma Paper of the Day, July 27th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Novel immune checkpoint inhibitor selectively prevents HLA-E: NKG2A interaction and activates NK cells against tumor cells presenting HLA-E-peptide complexes, potentially minimizing toxicity versus current NKG2A inhibitors.”

Title: HLA-E [pHLA-G] Complex Specific Monoclonal Antibody Enhancing NK Activity in Multiple Myeloma

Authors: Muhammad Abu Ahmad, Olga Radinsky, Bar Kaufman, Kamran Waidha, Eman Gharra, Sharon Dim, Dinesh Babu Manikandan, Noa Ofir, Dirk Jäger, Marten Meyer, Moshe Elkabets, Kerry S. Campbell, Miri Zektser, Roi Gazit, Ory Rouvio, Frank Momburg, Angel Porgador

You can read the Full Article in Blood Advances.

Myeloma Paper of the Day, July 27th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Angel Porgador Bar Kaufman blood advances cancer Dinesh Babu Manikandan Dirk Jäger Eman Gharra Frank Momburg Kamran Waidha Kerry S. Campbell Marten Meyer Miri Zektser Moshe Elkabets Muhammad Abu Ahmad Myeloma Myeloma Paper of the Day Noa Ofir Olga Radinsky OncoDaily Oncology Ory Rouvio Robert Orlowski Roi Gazit Sharon Dim

Uhm Jung-hwa: Korea’s Iconic ‘Madonna’ and Her Triumphant Battle Against Thyroid Cancer

Vincent Rajkumar: A Historic Day for High Risk Smoldering Myeloma

Dr. Anastasia Constantinidou Nominated for Madame Figaro Woman of the Year 2025

Lisa A. Lacasse Welcomed Shane Jacobson as the New CEO of the ACS and the ACS CAN

ASCO and Community Oncology Alliance Have Released the Updated Oncology Medical Home Standards